| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
16,221 |
13,128 |
$626K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
8,057 |
6,887 |
$475K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
9,232 |
8,219 |
$261K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
3,640 |
3,368 |
$235K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
3,353 |
2,850 |
$185K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
2,829 |
2,620 |
$175K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
1,820 |
1,592 |
$121K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
1,870 |
1,738 |
$66K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
4,104 |
3,601 |
$41K |
| 96160 |
|
3,168 |
2,703 |
$41K |
| 92551 |
|
5,750 |
5,153 |
$37K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,483 |
1,298 |
$37K |
| 99173 |
|
5,800 |
5,196 |
$28K |
| 96161 |
|
3,106 |
2,533 |
$28K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,131 |
951 |
$24K |
| 99174 |
|
2,589 |
2,342 |
$23K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
203 |
173 |
$18K |
| 99383 |
|
260 |
237 |
$18K |
| 99215 |
Prolong outpt/office vis |
229 |
195 |
$18K |
| 99381 |
|
229 |
198 |
$15K |
| 96127 |
|
3,939 |
3,218 |
$14K |
| 83655 |
|
882 |
830 |
$14K |
| 90651 |
|
1,035 |
898 |
$11K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
89 |
83 |
$11K |
| 99382 |
|
148 |
128 |
$10K |
| 99239 |
Hospital discharge day management, more than 30 minutes |
151 |
105 |
$7K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
150 |
138 |
$7K |
| 81003 |
|
3,407 |
2,967 |
$6K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
543 |
520 |
$6K |
| 85018 |
|
1,438 |
1,322 |
$4K |
| 94760 |
|
8,138 |
6,831 |
$4K |
| 99460 |
|
86 |
58 |
$3K |
| 90670 |
|
2,841 |
2,533 |
$3K |
| 90734 |
|
741 |
657 |
$3K |
| 90716 |
|
1,575 |
1,444 |
$3K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
102 |
78 |
$2K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
50 |
45 |
$2K |
| 90698 |
|
2,811 |
2,499 |
$2K |
| 90707 |
|
1,561 |
1,433 |
$1K |
| 90686 |
|
2,883 |
2,600 |
$1K |
| 94664 |
|
82 |
80 |
$1K |
| 90621 |
|
75 |
57 |
$1K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
48 |
47 |
$777.01 |
| 90680 |
|
1,815 |
1,579 |
$772.17 |
| 90715 |
|
370 |
326 |
$721.91 |
| 90633 |
|
1,776 |
1,634 |
$594.18 |
| 94010 |
|
13 |
13 |
$364.78 |
| 90696 |
|
413 |
386 |
$360.74 |
| 90744 |
|
1,549 |
1,401 |
$264.80 |
| 90713 |
|
78 |
73 |
$89.02 |
| 90700 |
|
138 |
122 |
$70.66 |
| 3008F |
|
7,626 |
6,882 |
$32.22 |
| 2000F |
|
383 |
354 |
$0.00 |
| 2001F |
|
428 |
396 |
$0.00 |
| 90674 |
|
138 |
134 |
$0.00 |
| 99072 |
|
159 |
145 |
$0.00 |
| 90685 |
|
187 |
158 |
$0.00 |
| 90658 |
|
121 |
119 |
$0.00 |